703676004: Canagliflozin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with cellular transport inhibitor mechanism of action (substance)\Sodium glucose cotransporter subtype 2 inhibitor\Canagliflozin

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Canagliflozin

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Sulfur and/or sulfur compound\Sulfur compound\Organic sulfur compound\Mercaptan compound\Thiophene\Canagliflozin

\Organic compound\Organic sulfur compound\Mercaptan compound\Thiophene\Canagliflozin

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Canagliflozin	Is a	Sodium glucose cotransporter subtype 2 inhibitor	true	Inferred relationship	Some
Canagliflozin	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Sodium glucose cotransporter subtype 2 inhibitor (disposition)	true	Inferred relationship	Some
Canagliflozin	Is a	Thiophene	true	Inferred relationship	Some
Canagliflozin	Is a	A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing canagliflozin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Canagliflozin	Inferred relationship	Some	1
Canagliflozin 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Canagliflozin	Inferred relationship	Some
Canagliflozin 500 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Canagliflozin	Inferred relationship	Some
Canagliflozin 300 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Canagliflozin	Inferred relationship	Some
Product containing canagliflozin and metformin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Canagliflozin	Inferred relationship	Some	2
Product containing canagliflozin and metformin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Canagliflozin	Inferred relationship	Some	2
Canagliflozin hemihydrate (substance)	Is a	False	Canagliflozin	Inferred relationship	Some
Canagliflozin 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Canagliflozin	Inferred relationship	Some	1
Canagliflozin 100 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Canagliflozin	Inferred relationship	Some	1
Product containing precisely canagliflozin 300 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Canagliflozin	Inferred relationship	Some
Canagliflozin 100 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Canagliflozin	Inferred relationship	Some	1
Canagliflozin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Canagliflozin	Inferred relationship	Some	1
Product containing only canagliflozin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Canagliflozin	Inferred relationship	Some	1
Canagliflozin and metformin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Canagliflozin	Inferred relationship	Some	2
Canagliflozin and metformin only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Canagliflozin	Inferred relationship	Some	2
Product containing only canagliflozin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Canagliflozin	Inferred relationship	Some	1
Canagliflozin hemihydrate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Canagliflozin	Inferred relationship	Some
Product containing precisely canagliflozin (as canagliflozin hemihydrate) 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Canagliflozin	Inferred relationship	Some	1
Product containing precisely canagliflozin 300 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Canagliflozin	Inferred relationship	Some	1
Product containing precisely canagliflozin 300 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Canagliflozin	Inferred relationship	Some	1
Allergy to canagliflozin	Causative agent (attribute)	True	Canagliflozin	Inferred relationship	Some	1
Canagliflozin anhydrous	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Canagliflozin	Inferred relationship	Some
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Canagliflozin	Inferred relationship	Some	2
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Canagliflozin	Inferred relationship	Some	2
Canagliflozin 150 mg and metformin hydrochloride 850 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Canagliflozin	Inferred relationship	Some	2
Canagliflozin 150 mg and metformin hydrochloride 850 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Canagliflozin	Inferred relationship	Some	2
Canagliflozin 150 mg and metformin hydrochloride 1 g oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Canagliflozin	Inferred relationship	Some	2
Canagliflozin 150 mg and metformin hydrochloride 1 g oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Canagliflozin	Inferred relationship	Some	2
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Canagliflozin	Inferred relationship	Some	2
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Canagliflozin	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3009197011	Canagliflozin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3009784017	Canagliflozin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
53591000195118	canaglifozin	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
372891000195110	canagliflozin	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
797271000172110	canagliflozine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
68511000195113	Canagliflozin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module